Our further cell cycle and western blotting assays verified that PRMT5 inhibition induced G1/S arrest in HCC cells by inhibiting Cyclin D1 and Cyclin E1, whereas pretreatment of cells with siRNA targeting BTG2 in shPRMT5‐HCC cells reversed this effect. Here, CCND1 is linked to hepatocellular carcinoma.